This past quarter, Core Laboratories reported earnings that held up much better than many expected. This has been a trend we've seen over the past several quarters. Core has been able to maintain ...

Earnings call Core Laboratories reported Q4 2025 revenue of $138.3M, up 3% sequentially and 7% YoY, with strong international service demand offsetting US softness. EPS ex items was $0.21, flat YoY.

CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...

HOUSTON, Oct. 9, 2023 /PRNewswire/ -- Halliburton Company (HAL) and Core Laboratories Inc. (NYSE: CLB) today announced a strategic collaboration in the U.S. to compress the delivery time of ...

Core Laboratories NV (CLB) reported its financial results for the third quarter of 2025, revealing earnings that fell short of analysts’ forecasts. The company posted earnings per share (EPS) of $0.22 ...

The deal will be conducted as an at-the-market (ATM) offering, with distribution partner banks selling shares into the market at prevailing prices. Like all stock offerings, this one will be dilutive ...

Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. Global markets in 2023 outperformed ...

HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory ...

Core Lab returned excess free cash to our shareholders by repurchasing more than 237,000 shares of company stock during the second quarter, a value of $2,700,000 In line with our stated financial ...